Skip to main content
TipRanks
Go Ultimate75% OFF

Mentari Therapeutics (MWG0) Ownership - Who Owns Mentari Therapeutics?

1 Followers

Mentari Therapeutics (MWG0) Ownership Overview

  • 39.34% Insiders
  • 60.66% Public Companies and Individual Investors

The ownership structure of Mentari Therapeutics (DE:MWG0) stock is a mix of institutional, retail, and individual investors. , 39.34% is owned by Insiders, and 60.66% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Oct 26, 2026Adar1 Capital Management, Llc$5
Oct 19, 2026Adar1 Capital Management, Llc$1,435
Oct 14, 2026Adar1 Capital Management, Llc$12,717
Oct 07, 2026Adar1 Capital Management, Llc$14,422

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

DE:MWG0 top shareholders
Holder# of SharesType% HoldingValue
Shane Aaron Johnson304,595Insider55.44%4,833,313
Eric A Adams43,959Insider8.00%697,541
Hull Andrew38,258Insider6.96%607,078

FAQ

What percentage of Mentari Therapeutics (DE:MWG0) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.66% of Mentari Therapeutics (DE:MWG0) stock is held by public companies and individual investors.
Who owns the most shares of Mentari Therapeutics (DE:MWG0)?
Shane Aaron Johnson owns the most shares of Mentari Therapeutics (DE:MWG0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.